OPKO Health Reports First Quarter 2018 Financial Results

OPKO Health (NASDAQ:OPK) reports financial results and business highlights for the three months ended March 31, 2018. As quoted in...

OPKO Health Announces Leadership Changes at BioReference Laboratories

OPKO Health (NASDAQ:OPK), announces that Gregory Henderson, M.D., Ph.D., has resigned from his position as President of BioReference Laboratories, an OPKO...

OPKO Subsidiary GenPath Women’s Health Announces Availability Of ClariTest

OPKO Health (NASDAQ:OPK) has announced GenPath Women's Health will begin offering ClariTest, a non-invasive prenatal test, to be performed initially...